Head-to-head · WeighScore
Sprout Health vs T2D.com
By GLP-1 ScorecardUpdated
Score comparison
Sprout Health has the higher recorded score — 79.8/100 to 53/100.
Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sprout advertises four-week compounded injection plans and separate annual prepayments; confirm the selected bill, pharmacy handoff and cancellation date.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Sprout Health | T2D.com |
|---|---|---|
| WeighScore | 79.8/100 | 53/100 |
| Grade | C+ | C |
| Site position | #26 | #516 |
| Semaglutide | $149/4 weeks (main-site offer; confirm selected plan) | $999/mo (starting dose, compounded) |
| Tirzepatide | $199/4 weeks (main-site offer; confirm selected plan) | $999/mo (starting dose, compounded) |
| Coverage | State exclusions in terms; confirm current eligibility | 1 state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #26 · C+
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Strengths
- Main-site compounded injection plans list $149 semaglutide / $199 tirzepatide per four weeks
- Evaluation, medication and shipping advertised as included
- Current policy allows a full refund before pharmacy transmission, including after clinical review
- Terms identify a clinical network and possible pharmacy contacts
What to consider
- The $99/$149 annual equivalents require $1,188/$1,788 upfront; selected offer terms need confirmation
- Four-week billing differs from calendar-month billing, and policy descriptions differ across plan types
- Cancellation requires 48-hour billing notice; shipment pauses need five business days
- Assigned clinician/pharmacy, state eligibility and current branded access remain unconfirmed
- An order becomes nonrefundable after pharmacy transmission; follow FDA guidance for warm injectable shipments
Site position #516 · C
Strengths
- Built specifically for type 2 diabetic and pre-diabetic patients
- Integrated service — prescriber, pharmacy, and delivery handled in one flow
- Offers both compounded semaglutide and compounded tirzepatide
- Temperature-controlled home delivery via UPS or FedEx
- Ongoing prescriber monitoring and support included
What to consider
- No pricing published on the public website — must register to see costs
- No states list published on the site
- Newer brand with limited independent reviews
- Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro
Featured provider
Sprout Health
Sprout Health scores 79.8/100 (C+). Sprout advertises four-week compounded injection plans and separate annual prepayments; confirm the selected bill, pharmacy handoff and cancellation date.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.